Stephan Cote - Reunion Neuroscience Head Quality

REUNDelisted Stock  USD 1.12  0.01  0.90%   

Insider

Stephan Cote is Head Quality of Reunion Neuroscience
Webhttps://www.fieldtriphealth.com

Reunion Neuroscience Management Efficiency

The company has return on total asset (ROA) of (0.2651) % which means that it has lost $0.2651 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8635) %, meaning that it created substantial loss on money invested by shareholders. Reunion Neuroscience's management efficiency ratios could be used to measure how well Reunion Neuroscience manages its routine affairs as well as how well it operates its assets and liabilities.
Reunion Neuroscience currently holds 3.37 M in liabilities. Reunion Neuroscience has a current ratio of 46.79, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Reunion Neuroscience's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Pr BayleyOxford Nanopore Technologies
N/A
Gordon SangheraOxford Nanopore Technologies
N/A
Joe FlanaganAccustem Sciences
49
Jordan HermanOxford Nanopore Technologies
N/A
Wilson WongSenti Biosciences
N/A
Anurag RelanPharming Group NV
51
Wendy BlosserAccustem Sciences
57
Jeroen WakkermanPharming Group NV
54
MBA MDPharming Group NV
63
John SchoellermanOxford Nanopore Technologies
N/A
Richard ComptonOxford Nanopore Technologies
N/A
Deborah KnobelmanSenti Biosciences
50
James CollinsSenti Biosciences
58
Darlene NociNuvalent
46
Christopher MDNuvalent
55
Prof ShairNuvalent
55
Rajkumar PatilOKYO Pharma Ltd
65
Sarah LapworthOxford Nanopore Technologies
N/A
Sara LeOxford Nanopore Technologies
N/A
Susanne EmbletonPharming Group NV
N/A
Gary JacobOKYO Pharma Ltd
77
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada. Reunion Neuroscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 194 people. Reunion Neuroscience (REUN) is traded on NASDAQ Exchange in USA and employs 16 people.

Management Performance

Reunion Neuroscience Leadership Team

Elected by the shareholders, the Reunion Neuroscience's board of directors comprises two types of representatives: Reunion Neuroscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Reunion. The board's role is to monitor Reunion Neuroscience's management team and ensure that shareholders' interests are well served. Reunion Neuroscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Reunion Neuroscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA, VP Director
Nathan BSc, Chief Officer
Stephan Cote, Head Quality
Hannan Fleiman, CoFounder Director
Mujeeb Jafferi, COFounder COO
Edward CPA, Chief Officer
Vicki Reed, Chief Officer
Curtis Weber, Gen Sec
JD Esq, CEO Pres
Matt Emmer, Director Devel

Reunion Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Reunion Neuroscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Reunion Neuroscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Reunion Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reunion Neuroscience will appreciate offsetting losses from the drop in the long position's value.

Moving against Reunion Stock

  0.89CMXHF CSL LimitedPairCorr
  0.88CSLLY CSLPairCorr
  0.87REGN Regeneron PharmaceuticalsPairCorr
  0.72NVO Novo Nordisk ASPairCorr
  0.71NONOF Novo Nordisk ASPairCorr
The ability to find closely correlated positions to Reunion Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Reunion Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Reunion Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Reunion Neuroscience to buy it.
The correlation of Reunion Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Reunion Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Reunion Stock

If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account